Souvenaid, a nutrient-rich drink costing £3.25 per day, is on sale from chemists today. It has been shown to improve the memory of those suffering from mild Alzheimer’s by helping to maintain brain synapses. These connections between nerve cells are gradually lost in Alzheimer’s, and with them the brain’s ability to retain new memories.
The research team at Massachusetts Institute of Technology have concluded after a 15 year study that the drink helps the body repair the damage done to the membranes and clinical trials showed definite memory improvement in the mild level sufferers, though there is no guarantee that daily activities will be improved as a result.
The drink contains a cocktail of B vitamins, omega-3 fatty acids, choline – which the body uses to make a vital nerve-signalling chemical, and phospholipids – a component of cell membranes. (Daily Telegraph 6.1.13 and Daily Express 14.1.13)
It’s been found that Beta Blockers are linked to lower Alzheimer’s risk after the brains of those who had taken the common blood pressure drugs were found to have fewer changes linked to Alzheimer’s disease. (Telegraph 8.1.13)
Advances in Alzheimer Research suggest that a once-a-day pill could stop the disease from progressing within a few years if clinical trials are successful. The trial of MK-8931, a drug which could halt the build up of amyloid plaque in the brain, has already started across 1700 people with mild to medium Alzheimer’s. (Daily Telegraph 5.12.12)